Generation Bio Co (GBIO) - Utang marang Ekuitas

GBIO (Generation Bio Co.) - tandha merek perusahaan

The market trend for Generation Bio Co. (GBIO) shown on this price chart demonstrates a debt-to-equity ratio of 0.56. The business focuses on creating breakthrough non-viral genetic material delivery methods. Unique patents and strict FDA oversight ensure a high barrier to entry. Current R&D expenses are funded by existing cash reserves.

GBIO: Total Utang marang Modal Generation Bio Co 04.07.2022 - 21.02.2026

Rincian metrik komprehensif lan analitis Generation Bio (GBIO)

- rega lan prakiraan konsensus rega:
Rega saham Generation Bio Co|GBIO - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Generation Bio|GBIO - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Generation Bio|GBIO - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku generationbio.com|GBIO - Aset Neraca Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Generation Bio Co.|GBIO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Generation Bio Co|GBIO - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Generation Bio
Analisis dhasar perusahaan:Generation Bio Co. GBIO
Sampel barang Generation Bio Co

Steady demand for Generation Bio Co. (GBIO) biotechnological innovations insulates the business from macroeconomic shocks, creating a foundation for sustainable growth. Analyzing the company's financial leverage dynamics, an investor assesses the debt-to-equity ratio to determine the level of debt burden and the risk of losing control over assets to creditors.

Pesaing wigati

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|Total Utang marang Modal WGS|RARE - Rasio Utang marang Modal|Total Utang marang Modal BEAM|SRPT (Sarepta Corp) - Utang marang Modal|Utang marang Ekuitas Twist Bioscience (TWST)|Rasio Utang marang Ekuitas 10xgenomics.com|Intellia Therapeutics, Inc. - Total Utang marang Modal|Utang marang Modal STOK (Stoke Therapeutics Inc)|Utang marang Ekuitas BioLife Corp|Rasio Kabeh Utang marang Dana Pribadi Wave Pharma WVE|Maze Therapeutics Inc - Total Utang marang Modal|sionnatx.com (SION) - Total Utang marang Modal|PRME - Rasio Total Utang marang Ekuitas|Taysha Gene Therapies Inc (TSHA) - Utang Agregat marang Modal|QURE: Total Utang marang Modal|Koefisien Total Utang marang Modal MGTX|REGENXBIO Inc. - Utang marang Ekuitas|Utang marang Modal SLDB (solidbio.com)|OCGN - Utang marang Ekuitas|PACB - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Benitec (BNTC)|DSGN - Rasio Kabeh Utang marang Dana Pribadi|Rocket Pharmaceuticals (RCKT) - Total Utang marang Modal|4dmoleculartherapeutics.com (FDMT) - Utang marang Ekuitas|LXEO: Total Utang marang Modal|Koefisien Total Utang marang Modal KRRO|Editas - Utang marang Ekuitas|Utang marang Modal Silence Therapeutics Corp SLN|Rasio Total Utang marang Ekuitas ProQR Therapeutics|Rasio Kabeh Utang marang Dana Pribadi Codexis Inc CDXS|SGMO: Total Utang marang Modal|NAUT: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas MGX|Utang marang Modal Precision BioSciences Inc.|BOLD: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Exicure Corp|IMNN: Total Utang marang Modal|Rasio Utang marang Modal phiopharma.com (PHIO)|Total Utang marang Modal Mustang Bio MBIO|Utang marang Ekuitas TransCode Therapeutics Inc. RNAZ|Total Utang marang Modal BNGO (Bionano)|APDN: Koefisien Total Utang marang Modal|Utang marang Ekuitas BLUE|ImmunoPrecise Antibodies Ltd. (IPA) - Utang marang Modal|Total Utang marang Modal Omega (OMGA)|Rasio Utang marang Ekuitas OMIC|Utang marang Ekuitas Regulus Therapeutics RGLS|Rasio Utang marang Ekuitas syros.com (SYRS)|Total Utang marang Modal TBIO (Telesis Bio)|Total Utang marang Modal TRACON Pharmaceuticals Inc. TCON|Total Utang marang Modal UBX